Endokinins are
tachykinin peptides designated from a human
preprotachykinin C (PPT-C, TAC4) gene and consist of endokinin A (EKA), endokinin B (EKB), endokinin C (EKC) and endokinin D (EKD). A representative of mammalian
tachykinins is
substance P (SP), which functions as a
neurotransmitter or modulator in the
pain system; however, little is known about the role of these endokinins, especially EKC and EKD, in
pain processing. Therefore, we evaluated the effects of EKC/D (using the common carboxyl-terminal duodecapeptide in EKC and EKD) on
pain processing in rats. Pretreatment with EKC/D prevented induction of scratching behavior and
thermal hyperalgesia by intrathecal administration of EKA/B (using the common C-terminal decapeptide in EKA and EKB) and SP and c-Fos expression in laminae I/II and V/VI of the spinal cord by noxious thermal stimulation. A prominent difference between EKC/D and SP is the presence of
leucine instead of
methionine at the carboxyl-terminal of EKC/D. Thus, to clarify whether
leucine at the carboxyl-terminal of EKC/D plays an important role in determining the inhibitory effect of this
peptide, we intrathecally administered [Met(12)]-EKC/D in which only
leucine of EKC/D is replaced by
methionine. This
peptide did not exhibit the inhibitory effect on SP-induced scratching behavior or
thermal hyperalgesia but conversely caused
thermal hyperalgesia. Taken together, these findings indicate that EKC/D has an inhibitory effect on
pain processing in the rat spinal cord, and the effect is due to
leucine at the carboxyl-terminal of EKC/D.